Tag: global companion animal veterinary vaccines market

  • Global Companion Animal Veterinary Vaccines Market Analysis 2025–2029: Opportunities for Strategic Growth

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    How Is The Companion Animal Veterinary Vaccines Market Size Likely To Evolve From 2025 Through 2034?

    The companion animal veterinary vaccines market size has experienced strong growth in recent years. It is projected to increase from $3.7 billion in 2024 to $3.94 billion in 2025, at a compound annual growth rate (CAGR) of 6.5%. The expansion observed in the historic period can be attributed to factors such as pet ownership growth, an emphasis on preventive healthcare, the impact of zoonotic diseases, and advancements in vaccine technology.

    The companion animal veterinary vaccines market is projected to experience robust expansion over the coming years. By 2029, its valuation is anticipated to reach $5.05 billion, demonstrating a compound annual growth rate (CAGR) of 6.4%. This anticipated growth during the forecast period is primarily driven by factors such as a rising pet population, heightened awareness regarding preventive healthcare, advancements in technology and vaccine creation, and the development of personalized vaccination strategies. Key emerging patterns for this period involve the implementation of extensive vaccination initiatives, innovative vaccine technologies, enhanced control over vector-borne diseases, and the proliferation of vaccination clinics and mobile veterinary services.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3370&type=smp

    What Are The Key Drivers Of Growth In The Companion Animal Veterinary Vaccines Market?

    The expansion of the companion animal veterinary vaccine market during the forecast period is linked to the rising pet ownership among Gen X and Gen Y adults. According to the APPA, millennials (Gen Y) constitute the largest segment of pet owners across various pet types. More than 80% of Gen Y and Gen Z individuals possess dogs, while 50% or less own cats as pets. The phenomenon of multiple pet ownership is also seeing an increase globally. For instance, in 2022, Animal Medicines Australia, an Australia-based non-governmental organization, reported a substantial growth in pet ownership within Australia, with the number of pet owners reaching 28,730.8 in 2022, a notable rise from 39% in 2021. This signifies a 24% increase, highlighting a robust upward trend in pet adoption and investment in their care. This significant increase in pet ownership underscores the growing popularity of pets in Australian households, which in turn contributes to the growth of the companion animal veterinary vaccine market.

    What Are The Major Segment Categories Driving The Companion Animal Veterinary Vaccines Market Growth?

    The companion animal veterinary vaccines market covered in this report is segmented –

    1) By Product: Inactivated, Live Attenuated, Recombinant, Other Products

    2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

    3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels

    Subsegments:

    1) By Inactivated: Inactivated Canine Vaccines, Inactivated Feline Vaccines, Inactivated Vaccine Combinations, Other Inactivated Vaccines

    2) By Live Attenuated: Live Attenuated Canine Vaccines, Live Attenuated Feline Vaccines, Live Attenuated Vaccine Combinations, Other Live Attenuated Vaccines

    3) By Recombinant: Recombinant Canine Vaccines, Recombinant Feline Vaccines, Recombinant Vaccine Combinations, Other Recombinant Vaccines

    4) By Other Products: DNA Vaccines, Subunit Vaccines, Toxoid Vaccines, Other Veterinary Vaccine Products

    Which Ongoing Trends Are Expected To Shape The Companion Animal Veterinary Vaccines Market Outlook?

    Within the companion animal veterinary vaccine industry, companies are increasingly forming collaborations and partnerships to propel product innovations. To achieve success in the highly competitive veterinary market, companion animal veterinary vaccine companies are expanding into new territories and developing advanced products by sharing skills and expertise with other entities. For example, MSD Animal Health, a subsidiary of Merck & Co., announced a strategic alliance with Vinovo B.V., a division of Viscon Hatchery Automation, the prominent hatchery automation company, to establish a new benchmark in secure and effective Vinovo vaccination to enhance bird welfare and diminish vaccine reactions.

    Which Industry Leaders Are Driving Innovation Across The Companion Animal Veterinary Vaccines Market?

    Major companies operating in the companion animal veterinary vaccines market include C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, Heska Corp., Merck and Co. Inc., Elanco Animal Health Incorporated, Zoetis Inc., Ceva Sante Animale SA, Bayer AG, Neogen Corporation, ImmuCell Corporation, Intervet Inc., Vetoquinol SA, IDEXX Laboratories Inc., Merial Inc., Biogenesis Bago SA, Hipra India Pvt. Ltd., Bimeda Animal Health Limited, Phibro Animal Health Corporation, Nexvet Biopharma plc, Bioniche Animal Health Canada Inc., Bioiberica S.A., Laboratorios Hipra S.A., Norbrook Laboratories Ltd., Dechra Pharmaceuticals PLC, Kyoritsu Seiyaku Corporation, VDS Pharma Animal Health, Kepro Technologies Private Limited, ECO Animal Health Group plc, Biostadt India Limited, bio-pharmaceutical company, Choong Ang Vaccine Laboratories Co. Ltd., CZ Veterinaria S.A.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

    What Are The Key Regional Factors Influencing The Companion Animal Veterinary Vaccines Market Growth?

    North America was the largest region in the companion animal veterinary vaccines market in 2024. Asia-Pacific was the second-largest region in the companion animal veterinary vaccines market. The regions covered in the companion animal veterinary vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Request A Customized Version Of The Companion Animal Veterinary Vaccines Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=3370&type=smp

    Browse Through More Reports Similar to the Global Companion Animal Veterinary Vaccines Market 2025, By The Business Research Company

    Veterinary Pharmaceuticals Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

    Animal Medicine Market 2025

    https://www.thebusinessresearchcompany.com/report/animal-medicine-market

    Veterinary Medical Equipment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/veterinary-medical-equipment-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • What Will The Companion Animal Veterinary Vaccines Market Look Like In 2023?

    What Will The Companion Animal Veterinary Vaccines Market Look Like In 2023?

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

    The Business Research Company’s companion animal veterinary vaccines market report forecasts the companion animal veterinary vaccines market size to grow to $4.48 Billion by 2027, with a CAGR (compound annual growth rate) of more than 6%.

    Learn More On The Companion Animal Veterinary Vaccines Market Report 2023 – https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

    Companion Animal Veterinary Vaccines Market Size Forecast

    The global companion animal veterinary vaccines market is expected to grow from $3.25 billion in 2022 to $3.47 billion in 2023 at a compound annual growth rate (CAGR) of 6.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global companion animal veterinary vaccines market size is expected to grow to $4.48 billion in 2027 at a CAGR of 6.6%.

    North America held the largest companion animal veterinary vaccines market share.

    Key Companion Animal Veterinary Vaccines Market Driver ­– Increase In Pet Ownership By Gen X And Gen Y Adults

    According to the APPA, millennials, or Gen Y, represent the largest segment of pet owners for all types of pets. More than 80% of Gen Y and Gen Z own a dog, and 50% or less own a cat as a pet. Multiple pet ownership is also on the rise in some parts of the world. According to the 2019-2020 APPA National Pet Owners Survey, 67% of US households own pets, which is equal to 84.9 million homes. Pet owners are well aware of advanced facilities and are willing to spend a large amount of money on the health of their pets. Therefore, the rise in pet ownership aids in the growth of the companion animal veterinary vaccine market.

    Request for A Sample Of The Global Companion Animal Veterinary Vaccines Market Report:
    https://www.thebusinessresearchcompany.com/sample.aspx?id=3370&type=smp

    Key Companion Animal Veterinary Vaccines Market Trend – Product Innovations

    Companies in the companion animal veterinary vaccine industry are increasingly collaborating and partnering with other players to drive product innovations. To succeed in the increasingly competitive veterinary market, companion animal veterinary vaccine companies are entering into new geographies and developing innovative products through sharing skills and expertise with other players. For instance, Merck & Co.’s subsidiary MSD Animal Health announced a strategic partnership with Vinovo B.V., a division of Viscon Hatchery Automation, the leading hatchery automation company, to provide a new standard in safe and effective Vinovo vaccination to improve bird welfare and reduce vaccine reactions.

    Companion Animal Veterinary Vaccines Market Segment

    1) By Product: Inactivated, Live Attenuated, Recombinant, Other Products

    2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

    3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels

    Companion Animal Veterinary Vaccines Market Major Players and Strategies

    Major players in the companion animal veterinary vaccines market are Boehringer Ingelheim, Eli Lilly and Company (Elcano), Heska Co., Merck Animal Health, Virbac, Zoetis, ElancoCevaSante Animal S.A., Bayer Healthcare, NEOGEN CORPORATION, and ImmuCell Corporation.

    In February 2020, Zoetis, Inc., a US-based animal health company specializing in the discovery, development, production, and marketing of animal health drugs, acquired Ethos Diagnostic Science for an undisclosed amount. Through this acquisition, Zoetis continues to expand its diagnostics presence in order to provide American veterinarians with comprehensive services at an improved value. Ethos Diagnostic Science is a US-based veterinary diagnostic company pioneering in various types of diagnostic testing and clinical chemistry.

    The Companion Animal Veterinary Vaccines Global Market Report 2023 covers regional data on companion animal veterinary vaccines market size, companion animal veterinary vaccines market trends and drivers, opportunities, strategies, and companion animal veterinary vaccines market competitor analysis. The countries covered in the companion animal veterinary vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

    Companion animal vaccines are substances that are used to stimulate the production of antibodies and provide immunity against one or several diseases in pets such as dogs, birds, and cats. They are also used to improve food digestion, enhance immunity, enable animals to gain fat and weight, and generate good quality meat that is harvested for commercial purposes.

    View More Reports Related To The Companion Animal Veterinary Vaccines Market –
    Veterinary Medical Equipment Global Market Report 2023
    Veterinary Patient Monitoring Equipment Global Market Report 2023
    Veterinary Pharmaceuticals Global Market Report 2023

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/
    Americas
    +1 3156230293
    Asia +44 2071930708
    Europe +44 2071930708
    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company
    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
    Found this article helpful? Share it on: